Abstract
The many obvious differences between simple and more complex multicellular organisms mask the extraordinarily high degree of conservation of the basic life processes and the proteins involved in them. The evolutionary conservation of many essential genes allows knowledge gained from mutational studies in simpler organisms to be used to identify the corresponding genes in mammals. The function of mammalian homologues can then be investigated by gene targeting in mice. Early development in the fruitfly Drosophila melanogaster is far more accessible to investigation than corresponding mammalian processes and many interesting genes involved in early development in this organism have been identified and isolated. Embryos carrying null alleles of the Drosophila melanogaster flightless I (fliI) gene exhibit only partial cellularization and gastrulation fails. Weak alleles of fliI result in adult flies lacking flight ability and exhibiting abnormal indirect flight muscle ultrastructure. The fliI gene was pos itionally cloned and the predicted protein of 1256 amino acids found to contain leucine-rich-repeat (LRR) and gelsolin-like domains. Homologues of fliI have subsequently been cloned from C. elegans, human (FLII) and mouse (Fliih) via PCR. FLII maps to 17p11.2, into a region affected in Smith-Magenis syndrome and in childhood primitive neuroectodermal tumours. The gelsolin domain interacts with G-actin in a Ca2+-independent manner, and has F-actin binding and severing activities. FLAP1 and FLAP2, novel ligands for the LRR domain detected in the yeast two-hybrid system, are derived from related mammalian genes. FLAP2 has been independently reported as an HIV-1 TAR RNA binding protein and as a transcriptional repressor. The LRR has been shown to interact with Ras both in vitro, and in vivo in yeast. Genomics-based studies on fliI and its homologues have opened up their involvement in a novel pathway of cytoskeletal regulation which appears to play an essential role in early development.
Keywords: Drosophila melanogaster flightless I Gene, Fliih, Human FLlII, Mouse homologues, FLII, Flightless 1 mutations, Human FLII, PNETs, Primitive neuroectodermal tumors, LRR Domain
Current Genomics
Title: Mammalian Homologues of the Drosophila melanogaster flightless I Gene Involved in Early Development
Volume: 1 Issue: 1
Author(s): H. D. Campbell, I. G. Young and K. I. Matthaei
Affiliation:
Keywords: Drosophila melanogaster flightless I Gene, Fliih, Human FLlII, Mouse homologues, FLII, Flightless 1 mutations, Human FLII, PNETs, Primitive neuroectodermal tumors, LRR Domain
Abstract: The many obvious differences between simple and more complex multicellular organisms mask the extraordinarily high degree of conservation of the basic life processes and the proteins involved in them. The evolutionary conservation of many essential genes allows knowledge gained from mutational studies in simpler organisms to be used to identify the corresponding genes in mammals. The function of mammalian homologues can then be investigated by gene targeting in mice. Early development in the fruitfly Drosophila melanogaster is far more accessible to investigation than corresponding mammalian processes and many interesting genes involved in early development in this organism have been identified and isolated. Embryos carrying null alleles of the Drosophila melanogaster flightless I (fliI) gene exhibit only partial cellularization and gastrulation fails. Weak alleles of fliI result in adult flies lacking flight ability and exhibiting abnormal indirect flight muscle ultrastructure. The fliI gene was pos itionally cloned and the predicted protein of 1256 amino acids found to contain leucine-rich-repeat (LRR) and gelsolin-like domains. Homologues of fliI have subsequently been cloned from C. elegans, human (FLII) and mouse (Fliih) via PCR. FLII maps to 17p11.2, into a region affected in Smith-Magenis syndrome and in childhood primitive neuroectodermal tumours. The gelsolin domain interacts with G-actin in a Ca2+-independent manner, and has F-actin binding and severing activities. FLAP1 and FLAP2, novel ligands for the LRR domain detected in the yeast two-hybrid system, are derived from related mammalian genes. FLAP2 has been independently reported as an HIV-1 TAR RNA binding protein and as a transcriptional repressor. The LRR has been shown to interact with Ras both in vitro, and in vivo in yeast. Genomics-based studies on fliI and its homologues have opened up their involvement in a novel pathway of cytoskeletal regulation which appears to play an essential role in early development.
Export Options
About this article
Cite this article as:
Campbell D. H., Young G. I. and Matthaei I. K., Mammalian Homologues of the Drosophila melanogaster flightless I Gene Involved in Early Development, Current Genomics 2000; 1 (1) . https://dx.doi.org/10.2174/1389202003351742
DOI https://dx.doi.org/10.2174/1389202003351742 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cardiovascular Effects of the Phytoestrogen Genistein
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Stroke in Women - Oral Contraception, Pregnancy, and Hormone Replacement Therapy
Current Vascular Pharmacology Sunscreening and Photosensitizing Properties of Coumarins and their Derivatives
Letters in Drug Design & Discovery Pathophysiological Bases of Eosinophilic Esophagitis Therapy
Inflammation & Allergy - Drug Targets (Discontinued) Prevention of Postprandial Metabolic Stress in Humans: Role of Fruit- Derived Products
Endocrine, Metabolic & Immune Disorders - Drug Targets Transforming Growth Factor-β: A Molecular Target for the Future Therapy of Glioblastoma
Current Pharmaceutical Design Digitalis-like Compounds: the Discovery of the O-aminoalkyloxime Group as a Very Powerful Substitute for the Unsaturated γ-Butyrolactone Moiety
Current Medicinal Chemistry Concerns and Hopes for Stem Cell Therapy in Cardiology: Focus on Endothelial Progenitor Cells
Cardiovascular & Hematological Disorders-Drug Targets A Comprehensive Review on Combretastatin Analogues as Tubulin Binding Agents
Current Organic Chemistry Circulating Biomarkers for the Diagnosis and Prognosis of Heart Failure
Current Medicinal Chemistry Identifying New Pathways and Targets for Wound Healing and Therapeutics from Natural Sources
Current Drug Delivery Modification of Collagen for Biomedical Applications: A Review of Physical and Chemical Methods
Current Organic Chemistry The Role of Endogenous H2S in Cardiovascular Physiology
Current Pharmaceutical Biotechnology Synthesis and Antiproliferative Effects of 5,6-Disubstituted Pyridazin-3(2H)-ones Designed as Conformationally Constrained Combretastatin A-4 Analogues
Anti-Cancer Agents in Medicinal Chemistry Sugar and Spice: Viral Envelope-DC-SIGN Interactions in HIV Pathogenesis
Current HIV Research Pitavastatin and 4-Hydroxy-3-Methoxyacetophenone (HMAP) Reduce Cognitive Dysfunction in Vascular Dementia During Experimental Diabetes
Current Neurovascular Research Therapeutic Targeting of Cancers with Loss of PTEN Function
Current Drug Targets “Oxygen Supply” as Modulator of Aging Processes: Hypoxia and Hyperoxia Models for Aging Studies
Current Aging Science Nicotinic Receptors Containing the α7 Subunit: A Model for Rational Drug Design
Current Medicinal Chemistry GSK-3 Inhibitors: A New Class of Drugs for Alzheimer’s Disease Treatment
Current Drug Targets